|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| Current assets: | ||||||||||||
| Cash and cash equivalents | ||||||||||||
| Time deposits under trade structured finance program (Note 3) | ||||||||||||
| Trade accounts receivable (net of allowances of $185 and $156) (Note 4) | ||||||||||||
| Inventories (Note 5) | ||||||||||||
| Assets held for sale (Note 2) | ||||||||||||
| Other current assets (Note 6) | ||||||||||||
| Total current assets | ||||||||||||
| Property, plant and equipment, net | ||||||||||||
| Operating lease assets | ||||||||||||
| Goodwill | ||||||||||||
| Other intangible assets, net | ||||||||||||
| Investments in affiliates | ||||||||||||
| Deferred income taxes | ||||||||||||
| Other non-current assets (Note 7) | ||||||||||||
| Total assets | ||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||
| Current liabilities: | ||||||||||||
| Short-term debt (Note 13) | ||||||||||||
| Current portion of long-term debt (Note 13) | ||||||||||||
| Letter of credit obligations under trade structured finance program (Note 3) | ||||||||||||
| Trade accounts payable (includes $776 and $559 carried at fair value) (Note 11) | ||||||||||||
| Current operating lease obligations | ||||||||||||
| Liabilities held for sale (Note 2) | ||||||||||||
| Other current liabilities (Note 10) | ||||||||||||
| Total current liabilities | ||||||||||||
| Long-term debt (Note 13) | ||||||||||||
| Deferred income taxes | ||||||||||||
| Non-current operating lease obligations | ||||||||||||
| Other non-current liabilities (Note 16) | ||||||||||||
| Redeemable noncontrolling interest | ||||||||||||
| Equity (Note 17): | ||||||||||||
| Registered shares, par value $0.01; authorized not issued – 33,632,445 shares; conditionally authorized 32,285,894 shares; issued and outstanding: 2026 – 192,142,343 shares, 2025 – 193,408,656 shares | ||||||||||||
| Common shares, par value $0.01; authorized—400,000,000 shares; issued and outstanding: 149,907,932 shares at December 31, 2022 | ||||||||||||
| Additional paid-in capital | ||||||||||||
| Retained earnings | ||||||||||||
| Accumulated other comprehensive income (loss) (Note 17) | ||||||||||||
| Treasury shares, at cost; 2026 - 16,369,420 shares and 2025 - 15,103,107 shares | ||||||||||||
| Total Bunge shareholders’ equity | ||||||||||||
| Noncontrolling interests | ||||||||||||
| Total equity | ||||||||||||
| Total liabilities, redeemable noncontrolling interest and equity |
Loading...